(Q80481862)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Relationship between matrix metalloproteinase 2 and lung cancer progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Chun-Bao Guo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Shan Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Chun Deng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Dian-Liang Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Fu-Ling Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Xian-Qing Jin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

Molecular Diagnosis and Therapy

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

183-192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17570740%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03256240

31 December 2019

exact match

0 references

cites work

Extracellular matrix remodelling: the role of matrix metalloproteinases

1 reference

12 December 2020

Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas

1 reference

12 December 2020

Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2

1 reference

12 December 2020

Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients

1 reference

12 December 2020

Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation

1 reference

12 December 2020

Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy

1 reference

12 December 2020

Measurement of the uncomplexed fraction of tissue inhibitor of metalloproteinases-1 in the prognostic evaluation of primary breast cancer patients

1 reference

12 December 2020

Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China

1 reference

12 December 2020

Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma

1 reference

12 December 2020

Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.

1 reference

12 December 2020

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

1 reference

12 December 2020

Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen

1 reference

12 December 2020

Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay

1 reference

12 December 2020

Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer

1 reference

12 December 2020

Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients.

1 reference

12 December 2020

Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence

1 reference

12 December 2020

Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region

1 reference

12 December 2020

Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer

1 reference

12 December 2020

K-ras regulates the steady-state expression of matrix metalloproteinase 2 in fibroblasts

1 reference

12 December 2020

Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker

1 reference

12 December 2020

Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters

1 reference

12 December 2020

Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer

1 reference

12 December 2020

Regulation of matrix metalloproteinase expression in tumor invasion.

1 reference

12 December 2020

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer

1 reference

12 December 2020

A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma

1 reference

12 December 2020

Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer

1 reference

12 December 2020

Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.

1 reference

12 December 2020

Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer

1 reference

12 December 2020

Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis

1 reference

12 December 2020

72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells

1 reference

12 December 2020

Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells

1 reference

12 December 2020

Serum levels of matrix metalloproteinase 2 in patients with breast cancer

1 reference

12 December 2020

Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9

1 reference

12 December 2020

Degradation of tenascin-C and activity of matrix metalloproteinase-2 are associated with tumor recurrence in early stage non-small cell lung cancer

1 reference

12 December 2020

Global analysis of gene expression in invasion by a lung cancer model.

1 reference

12 December 2020

Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain

1 reference

12 December 2020

Interstitial collagenases as markers of tumor progression

1 reference

12 December 2020

Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers

1 reference

12 December 2020

Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung

1 reference

12 December 2020